Gallstone disease: Current therapeutic practice

Current Treatment Options in Gastroenterology

Volumn 11, Issue 2, 2008, Pages 71-77

  Williams, Chad I ^a   Shaffer, Eldon A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYDROXYUREA; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; OPIATE; PLACEBO; SOMATOSTATIN DERIVATIVE; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ACUTE CHOLECYSTITIS; ALCOHOL CONSUMPTION; BARIATRIC SURGERY; BETA THALASSEMIA; BILIARY COLIC; CANCER RISK; CHOLANGITIS; CHOLECYSTECTOMY; CHOLESTASIS; CLINICAL TRIAL; DIABETES MELLITUS; DIET THERAPY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; EXTRACORPOREAL LITHOTRIPSY; GALLBLADDER CARCINOMA; GALLSTONE; HEMOLYSIS; HUMAN; LIFESTYLE MODIFICATION; NONHUMAN; OBESITY; ORGAN TRANSPLANTATION; PANCREATITIS; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; RISK REDUCTION; SICKLE CELL ANEMIA; WEIGHT REDUCTION;

EID: 54149100658     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-008-0018-6     Document Type: Review

References (47)

1. Russo MW, Wei JT, Thiny MT, et al.: Digestive and liver diseases statistics, 2004. Gastroenterology 2004, 126:1448-1453.
2. Sakorafas GH, Milingos I, Peros G: Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci 2007, 52:1313-1325.
3. NIH Consensus conference. Gallstones and laparoscopic cholecystectomy. JAMA 1993, 269:1018-1024.
4. Portincasa P, Moschetta A, Palasciano G: Cholesterol gallstone disease. Lancet 2006, 368:981-996.
5. Shaffer EA: GEllstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006, 20:981-996.
6. Grunhage F, Lammert F: Gallstone disease.APathogenesis of gallstones: a genetic perspective. Best Pract Res Clin Gastroenterol 2006, 20:997-1015.
7. Al-Jiffry BO, Shaffer EA, Saccone GT, et al.: Changes in gallbladder motility and gallstone formation following laparoscopic gastric banding for morbid obesity. Can J Gastroenterol 2003, 17:169-174.
8. Barbara L, Sama C, Morselli Labate AM, et al.: A population study on the prevalence of gallstone disease: The Sirmione Study. Hepatology 1987, 7:913-917.
9. Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D: Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med 1983, 99:199-204.
10. Venneman NG, Buskens E, Besselink MG, et al.: Small gallstones are associated with increased risk of acute pancreatitis: Potential benefits of prophylactic cholecystectomy? Am J Gastroenterol 2005, 100:2540-2550.
11. Misra S, Chaturvedi A, Misra NC, Sharma ID: Carcinoma of the gallbladder. Lancet Oncol 2003, 4:167-176.
12. Randi G, Franceschi S, La Vecchia C: Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006, 118:1591-1602.
13. Fuller W, Rasmussen JJ, Ghosh J, Ali MR: Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg 2007, 17:747-751.
14. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL: Long-term intake of dietary fiber and decreased risk of cholecystectomy in women. Am J Gastroenterol 2004, 99:1364-1370.
15. Tsai CJ, Leitzmann MF, Hu FB, et al.: Frequent nut consumption and decreased risk of cholecystectomy in women. Am J Clin Nutr 2004, 80:76-81.
16. Leitzmann MF, Stampfer MJ, Willett WC, et al.: Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology 2002, 123:1823-1830.
17. Leitzmann MF, Giovannucci EL, Rimm EB, et al.: The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med 1998, 128:417-425.
18. Leitzmann MF, Rimm EB, Willett WC, et al.: Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med 1999, 341:777-784.
19. Leitzmann MF, Giovannucci EL, Stampfer MJ, et al.: Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men. Alcohol Clin Exp Res 1999, 23:835-841.
20. Weinsier RL, Wilson LJ, Lee J: Medically safe rate of weight loss for the treatment of obesity: A guideline based on risk of gallstone formation. Am J Med 1995, 98:115-117.
21. Venneman NG, Besselink MG, Keulemans YC, et al.: Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology 2006, 43:1276-1283.
22. Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF: Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med 1995, 122:899-905.
23. Sugerman HJ, Brewer WH, Shiffman ML, et al.: A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995, 169:91-96; discussion 96-97.
24. Avila NA, Shawker TH, Roach P, et al.: Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: Incidence and time course. J Clin Ultrasound 1998, 26:289-294.
25. Hussaini SH, Pereira SP, Murphy GM, et al.: Composition of gall bladder stones associated with octreotide: Response to oral ursodeoxycholic acid. Gut 1995, 36:126-132.
26. Sitzmann JV, Pitt HA, Steinborn PA, et al.: Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 1990, 170:25-31.
27. Wu ZS, Yu L, Lin YJ, et al.: Rapid intravenous administration of amino acids prevents biliary sludge induced by total parenteral nutrition in humans. J Hepatobiliary Pancreat Surg 2000, 7:504-509.
28. Moschetta A, Bookout AL, Mangelsdorf DJ: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004, 10:1352-1358.
29. Doggrell SA: New targets in and potential treatments for cholesterol gallstone disease. Curr Opin Investig Drugs 2006, 7:344-348.
30. Wang DQ, Tazuma S: Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice. J Lipid Res 2002, 43:1960-1968.
31. Goldman G, Kahn PJ, Alon R, Wiznitzer T: Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci 1989, 34:809-811.
32. Ransohoff DF, Gracie WA: Treatment of gallstones. Ann Intern Med 1993, 119:606-619.
33. Keus F, BroedSrs IA, van Laarhoven CJ: Gallstone disease: surgical aspects of symptomatic cholecystolithiasis and acute cholecystitis. Best Pract Res Clin Gastroenterol 2006, 20:1031-1051.
34. Mentes BB, Akin M, Irkorucu O, et al.: Gastrointestinal quality of life in patients with symptomatic or asymptomatic cholelithiasis before and after laparoscopic cholecystectomy. Surg Endosc 2001, 15:1267-1272.
35. Dolan JP, Diggs BS, Sheppard BC, Hunter JG: Ten-year trend in the national volume of bile duct injuries requiring operative repair. Surg Endosc 2005, 19:967-973.
36. Khan MH, Howard TJ, Fogel EL, et al.: Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: Experience at a large tertiary referral center. Gastrointest Endosc 2007, 65:247-252.
37. Way LW, Stewart L, Gantert W, et al.: Causes and prevention of laparoscopic bile duct injuries: Analysis of 252 cases from a human factors and cognitive psychology perspective. Ann Surg 2003, 237:460-469.
38. Strasberg SM: Biliary injury in laParoscopic surgery: part 1. Processes used in determination of standard of care in misidentification injuries. J Am Coll Surg 2005, 201:598-603.
39. Torres WE, Steinberg HV, Davis RC, et al.: Extracorporeal shock wave lithotripsy of gallstones: Results and 6-month follow-up in 141 patients. Radiology 1991, 178:509-512.
40. Sauter G, Kullak-Ublick GA, Schumacher R, et al.: Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy. Gastroenterology 1997, 112:1603-1609.
41. Lau H, Lo CY, Patil NG, Yuen WK: Early versus delayed-interval laparoscopic cholecystectomy for acute cholecystitis: A metaanalysis. Surg Endosc 2006, 20:82-87.
42. do Amaral PC, Azaro Filho Ede M, Galvao TD, et al.: Laparoscopic cholecystectomy for acute cholecystitis in elderly patients. JSLS 2006, 10:479-483.
43. van Erpecum KJ: Gallstone disease. Complications of bile-duct stones: acute cholangitis and pancreatitis. Best Pract Res Clin Gastroenterol 2006, 20:1139-1152.
44. Chijiiwa K, Kozaki N, Naito T, et al.: Treatment of choice for choledocholithiasis in patients with acute obstructive suppurative cholangitis and liver cirrhosis. Am J Surg 1995, 170:356-360.
45. Acosta JM, Katkhouda N, Debian KA, et al.: Early ductal decompression versus conservative management for gallstone pancreatitis with ampullary obstruction: A prospective randomized clinical trial. Ann Surg 2006, 243:33-40.
46. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci Statements 2002, 19:1-26.
47. Rabago LR, Vicente C, Soler F, et al.: Two-stage treatment with preoperative endoscopic retrograde cholangiopancreatography (ERCP) compared with single-stage treatment with intraoperative ERCP for patients with symptomatic cholelithiasis with possible choledocholithiasis. Endoscopy 2006, 38:779-786.